2m 2m 2m 2m 2m 2m 2m
PRECISIO BIO (DTIL)
NASDAQ
$6.15-$0.17 (-2.69%)
Price as of Jun 03, 2026 7:14 PM EDT- $179.8MMarket Cap
- 22.72%1-Year Change
- BiotechnologyIndustry
PRECISIO BIO (DTIL)
$6.15-$0.17 (-2.69%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 34.3M -50.12% | 68.7M +40.98% | 48.7M +94.15% | 25.1M -78.28% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 34.3M -50.12% | 68.7M +40.98% | 48.7M +94.15% | 25.1M -78.28% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -54.2M -9.04% | -59.6M +11.59% | -53.4M -36.41% | -83.9M -27.16% | |
Depreciation and Amortization Expense | 1.5M -56.87% | 3.4M -50.07% | 6.8M -12.58% | 7.8M -13.17% | |
Total Operating Expenses | 86.4M -8.90% | 94.9M +2.59% | 92.5M -26.30% | 125.5M -19.02% | |
Operating Profit | -52.1M +99.33% | -26.2M -40.18% | -43.7M -56.42% | -100.4M +154.72% | |
Interest Income | 4.2M -37.32% | 6.8M -12.01% | 7.7M +121.31% | 3.5M +1,569.71% | |
Interest Expense | N/A N/A | -1.8M -20.09% | -2.2M +100.72% | -1.1M +741.67% | |
Interest Income and Expense and Net | 4.2M -14.90% | 5.0M -8.71% | 5.5M +130.99% | 2.4M +3,007.89% | |
Total Nonoperating Income and Expense | 5.5M -83.38% | 33.3M +2,656.74% | 1.2M +110.73% | -11.3M -228.08% | |
Income before Taxes | -52.1M +99.33% | -26.2M -40.18% | -43.7M -56.42% | -100.4M +154.72% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 36,000 N/A | N/A N/A | 10.8M -5.19% | 11.4M N/A | |
Net Income | -45.7M -737.98% | 7.2M +111.69% | -61.3M -45.07% | -111.6M +264.80% | |
Net Income from Continuing Operations Applicable to Common | -46.6M -750.33% | 7.2M +116.85% | -42.5M -61.91% | -111.6M +264.80% | |
Basic EPS and Net Income | -3.56 -439.05% | 1.05 +106.58% | -15.96 +1,156.69% | -1.27 +144.23% | |
Diluted EPS and Net Income | -3.56 -442.31% | 1.04 +106.52% | -15.96 +1,156.69% | -1.27 +144.23% | |
Basic Weighted Average Shares | 12.8M +87.71% | 6.8M +77.88% | 3.8M -95.63% | 87.9M +49.77% | |
Diluted Weighted Average Shares | 12.8M +86.32% | 6.9M +79.20% | 3.8M -95.63% | 87.9M +49.77% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 110.8M +29.02% | 85.9M -26.38% | 116.7M -38.45% | 189.6M +31.96% | |
Short-Term Investments | 4.8M +1,053.03% | 413,000 N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 115.6M +33.92% | 86.3M -26.03% | 116.7M -38.45% | 189.6M +31.96% | |
Total Current Assets | 118.7M +25.00% | 95.0M -30.34% | 136.4M -31.51% | 199.1M +23.09% | |
Accumulated Depreciation | 28.7M +2.19% | 28.1M +10.15% | 25.5M -18.01% | 31.1M +30.00% | |
Property and Plant and Equipment and Net | 1.4M -53.87% | 3.1M -51.26% | 6.3M -68.61% | 20.2M -19.73% | |
Total Long-Term Assets | 206,000 -6.79% | 221,000 -1.78% | 225,000 -91.25% | 2.6M -44.62% | |
Total Assets | 154.4M +13.22% | 136.4M -14.64% | 159.8M -32.91% | 238.2M +12.61% | |
Income Taxes Payable | 1.3M -40.17% | 2.1M -35.58% | 3.3M +180.57% | 1.2M -24.55% | |
Total Short-Term Debt | N/A N/A | 22.4M 0.00% | 22.4M N/A | N/A N/A | |
Total Current Liabilities | 8.9M -40.50% | 15.0M -70.03% | 50.0M -16.22% | 59.7M +65.83% | |
Total Long-Term Debt | 22.4M +0.37% | 22.3M +0.44% | 22.2M 0.00% | 22.2M +796.81% | |
Total Long-Term Liabilities | 259,000 +33.51% | 194,000 -3.48% | 201,000 0.00% | 201,000 +356.82% | |
Total Liabilities | 62.2M -22.29% | 80.0M -43.23% | 140.9M -20.71% | 177.7M +47.71% | |
Retained Earnings | -528.2M +9.48% | -482.5M -1.46% | -489.6M +14.32% | -428.3M +35.25% | |
Total Stockholders Equity | 92.2M +63.58% | 56.4M +198.99% | 18.9M -68.79% | 60.4M -33.71% | |
Total Shares Outstanding | 24.1M +193.66% | 8.2M +96.99% | 4.2M -96.25% | 111.0M +82.20% | |
Cash Flow | |||||
Cash from Operating Activities | -65.8M +12.66% | -58.4M -30.52% | -84.1M +83.84% | -45.8M +321.57% | |
Capital Expenditures | 85,000 -66.00% | 250,000 -87.23% | 2.0M -41.04% | 3.3M -34.32% | |
Cash from Investing Activities | -634,000 +194.88% | -215,000 -103.69% | 5.8M +275.63% | -3.3M -42.81% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 95.2M +88.63% | 50.5M +836.51% | 5.4M -94.33% | 95.0M +34.69% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -152.19% +299.63% | -38.08% -57.57% | -89.76% -77.55% | -399.90% +1,072.52% | |
Return on Assets | -31.45% -749.75% | 4.84% +115.70% | -30.82% -37.93% | -49.65% +193.40% | |
Return on Equity | -61.52% -423.00% | 19.05% +112.32% | -154.66% +5.01% | -147.28% +226.28% | |
Revenue Growth | -50.12% -222.30% | 40.98% -56.47% | 94.15% +220.28% | -78.28% -120.83% | |
Current Ratio | 13.32 +110.09% | 6.34 +132.45% | 2.73 -18.26% | 3.34 -25.77% | |
Cash Ratio | 12.43 +116.84% | 5.73 +145.66% | 2.33 -26.54% | 3.18 -20.42% | |
Debt-to-Equity Ratio | N/A N/A | 0.79 -66.48% | 2.37 N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | 0.33 +17.39% | 0.28 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow